Posizioni attive di Elmar Schärli
Società | Posizione | Inizio | Fine |
---|---|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Direttore Finanziario/CFO | - | - |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Elmar Schärli
Precedenti posizioni note di Elmar Schärli
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Direttore Finanziario/CFO | 01/11/2019 | 01/11/2021 |
Statistiche
Distribuzione geografica
Svizzera | 3 |
Bermuda | 2 |
Posizioni
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Settori
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Aziende private | 2 |
---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Elmar Schärli
- Esperienza